These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22538364)

  • 1. Biological markers in osteoarthritis.
    Rousseau JCh; Garnero P
    Bone; 2012 Aug; 51(2):265-77. PubMed ID: 22538364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers in osteoarthritis.
    Rousseau JC; Delmas PD
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):346-56. PubMed ID: 17538566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis value of biological markers CTX-II in osteoarthritis].
    Li ZN; Wei XC
    Zhongguo Gu Shang; 2008 Sep; 21(9):719-22. PubMed ID: 19105305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II collagen markers in osteoarthritis: what do they indicate?
    Henrotin Y; Addison S; Kraus V; Deberg M
    Curr Opin Rheumatol; 2007 Sep; 19(5):444-50. PubMed ID: 17762609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in osteoarthritis.
    Abramson S; Krasnokutsky S
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):77-81. PubMed ID: 17121495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical markers of bone turnover. New aspect. Biomarkers of cartilage metabolism].
    Okano T; Koike T
    Clin Calcium; 2009 Aug; 19(8):1149-58. PubMed ID: 19638699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular markers of osteoarthritis].
    Senolt L; Pavelka K
    Acta Chir Orthop Traumatol Cech; 2005; 72(3):191-6. PubMed ID: 16105504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body fluid markers of cartilage changes in osteoarthritis.
    Thonar EJ; Shinmei M; Lohmander LS
    Rheum Dis Clin North Am; 1993 Aug; 19(3):635-57. PubMed ID: 8210579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation.
    Bleasel JF; Poole AR; Heinegård D; Saxne T; Holderbaum D; Ionescu M; Jones P; Moskowitz RW
    Arthritis Rheum; 1999 Jan; 42(1):39-45. PubMed ID: 9920012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of biomarker CTX- II in osteoarthritis].
    Wang XZ; Gao NY; Liu T; Shen J; Wei SP; Zheng YX; Cao YL; Zhan HS
    Zhongguo Gu Shang; 2013 Mar; 26(3):260-3. PubMed ID: 23795452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the role of molecular markers to monitor disease, intervention, and cartilage breakdown in osteoarthritis.
    Lohmander LS; Felson DT
    J Rheumatol; 1997 Apr; 24(4):782-5. PubMed ID: 9101518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: Collagen markers in early arthritic diseases.
    Elsaid KA; Chichester CO
    Clin Chim Acta; 2006 Mar; 365(1-2):68-77. PubMed ID: 16257399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress toward biomarker identification in osteoarthritis.
    De Ceuninck F; Sabatini M; Pastoureau P
    Drug Discov Today; 2011 May; 16(9-10):443-9. PubMed ID: 21262380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
    Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
    Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological markers of osteoarthritis].
    Thonar EJ; Manicourt DH
    Rev Rhum Ed Fr; 1994 Nov; 61(9 Pt 2):99S-102S. PubMed ID: 7858614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subchondral bone as a key target for osteoarthritis treatment.
    Castañeda S; Roman-Blas JA; Largo R; Herrero-Beaumont G
    Biochem Pharmacol; 2012 Feb; 83(3):315-23. PubMed ID: 21964345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of cartilage turnover. Part 2: Non-collagenous markers.
    Garvican ER; Vaughan-Thomas A; Clegg PD; Innes JF
    Vet J; 2010 Jul; 185(1):43-9. PubMed ID: 20488734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.